Pharvaris (PHVS) Receivables (2019 - 2026)

Pharvaris (PHVS) posted Receivables of $1.1 million for Q1 2026, up 75.16% on a QoQ basis from $648068.4 in Q4 2025, and up 85.07% year-over-year from $613377.0 in Q1 2025.

Pharvaris (PHVS) Receivables (2019 - 2026) Analysis & Trends

Pharvaris' Receivables history runs 8 years deep, the most recent figure standing at $1.1 million for Q1 2026.

  • Quarterly Receivables rose 85.07% year-over-year to $1.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.1 million (up 85.07% YoY) and the FY2025 annual result came in at $5.1 million, up 61.34% from the prior year.
  • Receivables was $1.1 million for Q1 2026 at Pharvaris, up from $648068.4 in the prior quarter.
  • Across five years, Receivables topped out at $1.1 million in Q1 2026 and bottomed at $336205.7 in Q3 2023.
  • A 5-year average of $539213.5 and a median of $472442.4 in 2023 frame the typical range for Receivables.
  • Annual changes were most pronounced in 2022 — Receivables slumped 58.74% — and 2024, when it soared 110.82%.
  • Pharvaris' Receivables stood at $390212.0 in 2022, then rose by 16.77% to $455645.5 in 2023, then advanced by 7.37% to $489239.3 in 2024, then surged by 32.46% to $648068.4 in 2025, then surged by 75.16% to $1.1 million in 2026.
  • Business Quant data shows PHVS's Receivables at $1.1 million in Q1 2026, $648068.4 in Q4 2025, and $601795.0 in Q2 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Receivables (Qtr)
1 Oculis Holding AG 67,072.09 Bn 67,072.09 Bn - -
2 Nanobiotix 1,894.61 Bn 1,894.55 Bn - 4.97 Mn
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn - -
4 BeOne Medicines 471.64 Bn 466.85 Bn 1.35 Bn 938.02 Mn
5 Vertex Pharmaceuticals 121.72 Bn 114.47 Bn 2.59 Bn 2.00 Bn
6 Regeneron Pharmaceuticals 68.28 Bn 59.52 Bn 3.31 Bn 5.73 Bn
7 Belite Bio 61.40 Bn 61.40 Bn - -
8 Argenx Se 56.94 Bn 56.94 Bn 1.18 Bn -
9 Revolution Medicines 37.37 Bn 37.37 Bn - -
10 Pharvaris 2.22 Bn 1.94 Bn - 1.14 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 1.14 Mn
Dec 31, 2025 648,068.42
Jun 30, 2025 601,795.05
Mar 31, 2025 613,376.96
Dec 31, 2024 489,239.31
Sep 30, 2024 708,782.08
Jun 30, 2024 554,924.48
Mar 31, 2024 394,426.45
Dec 31, 2023 455,645.49
Sep 30, 2023 336,205.73
Jun 30, 2023 364,026.34
Mar 31, 2023 422,984.69
Dec 31, 2022 390,211.97
Sep 30, 2022 407,499.11
Jun 30, 2022 354,185.99
Mar 31, 2022 750,859.65
Dec 31, 2021 800,870.04
Sep 30, 2021 745,742.39
Jun 30, 2021 858,362.53
Mar 31, 2021 652,954.91